SYNRIBO Trademark

Trademark Overview

On Wednesday, January 11, 2012, a trademark application was filed for SYNRIBO with the United States Patent and Trademark Office. The USPTO has given the SYNRIBO trademark a serial number of 85514017. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, July 28, 2023. This trademark is owned by ChemGenex Pharmaceuticals Limited. The SYNRIBO trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of leukemia, dispensed in liquid or vial form for administration by subcutaneous injection
synribo

General Information

Serial Number85514017
Word MarkSYNRIBO
Filing DateWednesday, January 11, 2012
Status710 - CANCELLED - SECTION 8
Status DateFriday, July 28, 2023
Registration Number4277076
Registration DateTuesday, January 15, 2013
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 10, 2012

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of leukemia, dispensed in liquid or vial form for administration by subcutaneous injection

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, July 28, 2023
Primary Code005
First Use Anywhere DateMonday, November 12, 2012
First Use In Commerce DateMonday, November 12, 2012

Trademark Owner History

Party NameTEVA PHARMACEUTICALS INTERNATIONAL GMBH
Party Type31 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressJONA 8645
CH
Party NameIVAX INTERNATIONAL GMBH
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressRAPPERSWIL 8640
CH
Party NameIVAX INTERNATIONAL GMBH
Party Type21 - New Owner After Publication
Legal Entity Type99 - Other
AddressRAPPERSWIL 8640
CH
Party NameChemGenex Pharmaceuticals Limited
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressGeelong 3220
AU
Party NameChemGenex Pharmaceuticals Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressGeelong 3220
AU

Trademark Events

Event DateEvent Description
Friday, July 28, 2023CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
Saturday, January 15, 2022COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Friday, January 18, 2019NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Friday, January 18, 2019REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Friday, January 18, 2019CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, December 18, 2018TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, December 18, 2018TEAS SECTION 8 & 15 RECEIVED
Monday, January 15, 2018COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Wednesday, July 22, 2015AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, January 15, 2013REGISTERED-PRINCIPAL REGISTER
Friday, December 14, 2012NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Thursday, December 13, 2012LAW OFFICE REGISTRATION REVIEW COMPLETED
Sunday, December 9, 2012ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Friday, December 7, 2012STATEMENT OF USE PROCESSING COMPLETE
Monday, December 3, 2012USE AMENDMENT FILED
Friday, December 7, 2012CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, December 3, 2012TEAS STATEMENT OF USE RECEIVED
Wednesday, November 14, 2012AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Wednesday, October 17, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, October 15, 2012SOU EXTENSION 1 GRANTED
Monday, October 15, 2012SOU EXTENSION 1 FILED
Monday, October 15, 2012SOU TEAS EXTENSION RECEIVED
Tuesday, June 5, 2012NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 10, 2012OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 10, 2012PUBLISHED FOR OPPOSITION
Wednesday, March 21, 2012NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 6, 2012LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, March 6, 2012ASSIGNED TO LIE
Wednesday, February 15, 2012APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 15, 2012ASSIGNED TO EXAMINER
Tuesday, January 17, 2012NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, January 14, 2012NEW APPLICATION ENTERED

Related Keywords

synribo form administration subcutaneous injection vial liquid preparations treatment leukemia dispensed